Long-term hematologic improvement in a patient with cytopenic myelofibrosis treated with pacritinib

Authors

Abdulraheem Yacoub, University of Kansas
Ruben A Mesa, University of Texas Health Science - San Antonio
Stephen T Oh, Washington University School of Medicine in St. Louis

Journal

JCO Precision Oncology

Publication Date

1-12-2023

Volume

7

First Page

e2200523

Document Type

Open Access Publication

DOI

10.1200/PO.22.00523

Rights and Permissions

Yacoub A, Mesa RA, Oh ST. Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib. JCO Precis Oncol. 2023 Jan;7:e2200523. doi: 10.1200/PO.22.00523. Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/

Recommended Citation

Yacoub, Abdulraheem; Mesa, Ruben A; and Oh, Stephen T, "Long-term hematologic improvement in a patient with cytopenic myelofibrosis treated with pacritinib." JCO Precision Oncology. 7, e2200523 (2023).
https://digitalcommons.wustl.edu/oa_4/1299

Department

ICTS (Institute of Clinical and Translational Sciences)